Tag Archives: Medicines Australia

Seminar: The Advertising of Therapeutic Good and Services, March 17, 2016

Introduction This seminar was held back-to-back with World Consumer Rights Day 2016 (March 15) and the National Consumer Congress (March 16). The latter was hosted by the Australian Competition and Consumer Commission (ACCC). The 2016 Congress discussed how to better protect … Continue reading

Posted in Chiropractic, Complementary medicine, Education, Natural Therapies, Pharmaceutical Promotion | Tagged , , , , , , , , | 2 Comments

ABC RN Interview – Drug company marketing on doctor’s choices

This interview with Michael Mackenzie (ABC Radio National, Friday 28th August, 2015, 14:40 minutes) can be heard here. It was based on a recent lecture given to Monash University pharmacology students. by

Posted in Education, Pharmaceutical Promotion, Uncategorized | Tagged , , | Leave a comment

Drug promotion, advertising and ethical relationships with industry

Gave a lecture on this topic to Monash pharmacology students on August 21, 2015. A PDF version is available here. by

Posted in Pharmaceutical Promotion | Tagged , , , , | 1 Comment

The ‘No Advertising Please’ Campaign

I gave an invited presentation on this campaign to 1500 Australian Medical Students at their National Convention in Melbourne on July 6, 2015. It’s available for download here. by

Posted in Pharmaceutical Promotion | Tagged , , , | Leave a comment

Australian docs who accept pharma money must be named – ACCC

Australia’s competition and consumer watchdog (ACCC) has demanded that drug companies publicly name any doctor who accepts consultancy or speaker fees or free travel and accommodation. Unless this condition is complied with the ACCC will not authorise Medicines Australia’s latest … Continue reading

Posted in Uncategorized | Tagged , , , | Leave a comment

“No Advertising Please” NAP campaign (Prescribers need evidence, not marketing)

A nice launch of this campaign helped by the responses from: Medicines Australia (“the idea that you can ignore information from a pharmaceutical company that has conducted extensive research and development to help treat disease is laughable at best and negligent … Continue reading

Posted in Education, Pharmaceutical Promotion | Tagged , | 1 Comment

Self-regulation or government regulation of transparency?

In 2012, when edition 17 of Medicines Australia Code was released, the Australian Competition and Consumer Commission (ACCC) limited its authorisation to 2 years, rather than the 5 years sought, to encourage Medicines Australia to improve transparency around payments to … Continue reading

Posted in Pharmaceutical Promotion | Tagged , , | 1 Comment

Medical Observer podcast published

I discuss CAM regulation and therapeutic goods industry transparency with the former editor of the Medical Journal of Australia, Dr Annette Katelaris. The podcast is available at: http://tinyurl.com/l5s9ypv [Registration not necessary] For more on the current Medicines Australia Transparency Consultation see: http://www.medreach.com.au/?p=960 … Continue reading

Posted in Complementary medicine, Pharmaceutical Promotion | Tagged , , | Leave a comment

Medicines Australia Transparency Model Consultation

This matter (and others) was presented and discussed at a recent meeting of the Skeptics Groups of Victoria held at La Notte on Sept 1, 2013. For additional background: http://medicinesaustralia.com.au/issues-information/transparency-working-group/ http://www.theglobalmail.org/feature/directions-advise-get-paid-keep-quiet/688/ http://www.theglobalmail.org/feature/the-doctors-dilemma/603/ http://www.theglobalmail.org/feature/a-million-dollars-a-week/600/ In brief: Submissions should be sent to: secretarycodecommittee@medicinesaustralia.com.au by … Continue reading

Posted in Pharmaceutical Promotion | Tagged , | Leave a comment

How well does Australia control the promotion of therapeutic goods?

Yesterday, I gave an invited presentation to TGA staff in Canberra (and elsewhere by video-link).  I reviewed how well Australia had implemented the 2007 World Health Assembly’s (WHA) Resolution 60.16: “Wishing to promote evidence-based rational use of medicines by providers and consumers, … Continue reading

Posted in Pharmaceutical Promotion | Tagged , , , , , , , | 1 Comment